ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,755, issued on Feb. 17, was assigned to KYUNGSUNG UNIVERSITY INDUSTRY COOPERATION FOUNDATION (Busan, South Korea) and PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (Busan, South Korea).
"Cinnamic amide derivative having FXR activating effect, pharmaceutical composition containing the same as active ingredient, and method for preparing the same" was invented by Jae-Hwan Kwak (Busan, South Korea), Young-Suk Jung (Incheon, South Korea), Doyoung Kwon (Jeju-si, South Korea), Min Woo Kim (Busan, South Korea) and Sou Hyun Kim (Seoul, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a pharma...